<DOC>
	<DOCNO>NCT01447797</DOCNO>
	<brief_summary>The purpose study evaluate pharmacokinetics safety oral administration Irbesartan Atorvastatin combination HCP0912</brief_summary>
	<brief_title>A Bioequivalence Study Comparing Irbesartan/Atorvastatin Combination Tablet With Coadministration Irbesartan Atorvastatin</brief_title>
	<detailed_description />
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<mesh_term>Irbesartan</mesh_term>
	<criteria>Age 20 45 Signed inform consent form weight : 45kg range Â±20 % IBW Has medical history hypersensitivity atorvastatin irbesartan severe Hypotension Not eligible subject health examination within 28 day IP administration</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>September 2011</verification_date>
	<keyword>Irbesartan</keyword>
	<keyword>Atorvastatin</keyword>
	<keyword>combination</keyword>
</DOC>